Bladder cancer is the ninth most common cancer globally, and is the most expensive to…
sciencecityNovember 10, 2017
Genome BC is pleased to announce a staged investment of $750,000 into CuePath Innovation (CuePath)…
sciencecityNovember 9, 2017
Applications are now open for MSFHR's 2018 Scholar competition. The letter of intent deadline is December…
sciencecityNovember 8, 2017
Alzheimer's is the leading cause of dementia worldwide. The incurable disease slowly impairs cognitive function,…
sciencecityNovember 8, 2017
Alzheimer's is the leading cause of dementia worldwide. The incurable disease slowly impairs cognitive function,…
mjoyNovember 8, 2017
Novel immune checkpoint blockade strategies are being evaluated in clinical trials and include targeting the…
sciencecityNovember 8, 2017
Myelodysplastic syndrome (MDS) represents a group of diseases often referred to as bone marrow failure,…
sciencecityNovember 7, 2017
On Tuesday, November 7, six finalists will compete in the American Diabetes Association's (ADA) second-annual Venture…
sciencecityNovember 7, 2017
We discovered systemic immune response signatures that were highly correlated to upper airway clinical symptom…
sciencecityNovember 6, 2017
